https://www.newswise.com/articles/tofacitinib-shows-promise-in-scleroderma-patients-researchers-optimistic-for-next-phase-of-study
0
0
10/6/22 at 7:05pm
Organization
Newswise
35 words
0
Comments
The drug tofacitinib was well tolerated among patients with early scleroderma, primarily affecting the protein interferon both in fibroblasts and keratinocytes.
You are the first to view
Create an account
or login to join the discussion